Keefe, Bruyette & Woods analyst Michael Brown maintains TPG (NASDAQ:TPG) with a Market Perform and raises the price target from $37 to $38.
Argus Research Upgrades Allscripts Healthcare to Buy, Announces $26 Price Target
Argus Research analyst Jasper Hellweg upgrades Allscripts Healthcare (NASDAQ:MDRX) from Hold to Buy and announces $26 price target.